Cargando…

Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

Detalles Bibliográficos
Autores principales:	Martelli, Alberto M., Lonetti, Annalisa, Amadori, Sergio, McCubrey, James A., Chiarini, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Editorials: Cell Cycle Features
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735688/ https://www.ncbi.nlm.nih.gov/pubmed/23708511 http://dx.doi.org/10.4161/cc.25117

Ejemplares similares

Glutaminolysis feeds mTORC1
por: Durán, Raúl V., et al.
Publicado: (2012)

mTORC2 dictates Warburg effect and drug resistance
por: Masui, Kenta, et al.
Publicado: (2014)

Stress granules: The last refuge of TORC1?
por: Takahara, Terunao, et al.
Publicado: (2012)

A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia
por: Chiarini, Francesca, et al.
Publicado: (2012)

Biochemical heterogeneity and developmental varieties in T-cell leukemia
por: Chakraborty, Arup K., et al.
Publicado: (2013)

The hammer of TORC1!
por: Dufour, Eric
Publicado: (2015)

PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors
por: Lonetti, Annalisa, et al.
Publicado: (2015)

Do transcription factories and TOP2B provide a recipe for chromosome translocations in therapy-related leukemia?
por: Cowell, Ian G., et al.
Publicado: (2012)

Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
por: Evangelisti, Camilla, et al.
Publicado: (2018)

Therapeutic targeting of CK2 in acute and chronic leukemias
por: Buontempo, F, et al.
Publicado: (2018)

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
por: Martelli, Alberto M., et al.
Publicado: (2010)

Unfolding tyrosine kinase inhibitor sensitivity in chronic myeloid leukemia
por: Perrotti, Danilo, et al.
Publicado: (2012)

The Unfolded Protein Response: A Novel Therapeutic Target in Acute Leukemias
por: Martelli, Alberto M., et al.
Publicado: (2020)

A critical role for TORC1 in cellular senescence
por: Denchi, Eros Lazzerini
Publicado: (2012)

A critical role for mTORC1 in erythropoiesis and anemia
por: Knight, Zachary A, et al.
Publicado: (2014)

Defects in mTORC1 Network and mTORC1-STAT3 Pathway Crosstalk Contributes to Non-inflammatory Hepatocellular Carcinoma
por: Li, Ting, et al.
Publicado: (2020)

Transcriptional regulation of mTORC1 in cancer
por: Di Malta, Chiara, et al.
Publicado: (2018)

SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt
por: Meng, Haitao, et al.
Publicado: (2013)

Understanding the Roles of the Hedgehog Signaling Pathway during T-Cell Lymphopoiesis and in T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Martelli, Alberto M., et al.
Publicado: (2023)

Protein kinase CK2 opens the gate for zinc signaling
por: Taylor, Kathryn M., et al.
Publicado: (2012)

MALT lymphoma meets stem cells
por: Vicente-Dueñas, Carolina, et al.
Publicado: (2012)

IF1 reprograms energy metabolism and signals the oncogenic phenotype in cancer
por: Sánchez-Aragó, María, et al.
Publicado: (2012)

A long way to stemness
por: Samokhvalov, Igor M.
Publicado: (2012)

Manipulation of single polymerase-DNA complexes: A mechanical view of DNA unwinding during replication
por: Morin, Jose A., et al.
Publicado: (2012)

Through the looking-glass: Observing HSCs through the lens of infection reveals unexpected insights into HSC function
por: Hall, Christopher, et al.
Publicado: (2012)

Drosophila growth and development: Keeping things in proportion
por: Andersen, Ditte S., et al.
Publicado: (2012)

T-ARG-eting E2F-1 growth control
por: Moehlenbrink, Jutta, et al.
Publicado: (2012)

Turned on by genotoxic stress
por: Travesa, Anna, et al.
Publicado: (2012)

Too much or too little: Harnessing senescence to control oncogene-driven cancer
por: Hannan, Katherine M., et al.
Publicado: (2012)

Lack of communication rusts and ages stem cells
por: Ishikawa, Eri Taniguchi, et al.
Publicado: (2012)

Glucose homeostasis and p75(NTR): The sweet side of neurotrophin receptor signaling
por: Baeza-Raja, Bernat, et al.
Publicado: (2012)

A novel G(1) checkpoint mediated by the p57 CDK inhibitor and p38 SAPK promotes cell survival upon stress
por: Joaquin, Manel, et al.
Publicado: (2012)

The oncogenic transcription factor FOXM1 and anticancer therapy
por: Gartel, Andrei L.
Publicado: (2012)

A general requirement for FcγRIIB co-engagement of agonistic anti-TNFR antibodies
por: Li, Fubin, et al.
Publicado: (2012)

How a mismatch repair enzyme balances the needs for efficient lesion processing and minimal action on undamaged DNA
por: Drohat, Alexander C., et al.
Publicado: (2012)

How not to get cross(ed): A novel role for FANCM orthologs in meiotic recombination
por: Lorenz, Alexander, et al.
Publicado: (2012)

TLS/FUS: A protein in cancer and ALS
por: Tan, Adelene Y., et al.
Publicado: (2012)

Combination of isoform-selective histone/protein deacetylase inhibitors improves Foxp3+ T-regulatory cell function
por: Beier, Ulf H., et al.
Publicado: (2012)

p53 reactivation: The link to zinc
por: D’Orazi, Gabriella, et al.
Publicado: (2012)

p53 and cancer stem cells: The mevalonate connexion
por: Ginestier, Christophe, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lj2mh6pdeil76rf7nn74sm025u